AQST
Aquestive Therapeutics Inc
NASDAQ: AQST · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.10
+1.23% today
Updated 2026-04-30
Market cap
$509.57M
P/E ratio
—
P/S ratio
11.44x
EPS (TTM)
$-0.78
Dividend yield
—
52W range
$2 – $8
Volume
1.7M
Aquestive Therapeutics Inc (AQST) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2005 | 2006 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-6.39M | $-9.26M | $-8.18M | $5.82M | $-12.99M | $-60.21M | $-45.46M | $-32.98M | $-9.79M | $-6.38M | $-35.76M | $-52.43M |
| Capital expenditures | $2.76M | $3.38M | $976000.00 | $2.07M | $1.82M | $663000.00 | $517000.00 | $913000.00 | $2.52M | $995000.00 | $159000.00 | $562000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $29.94M | $7.07M | $6.58M | $6.82M | $4.38M | $2.69M | $7.10M | $7.62M |
| Free cash flow | $-9.16M | $-12.63M | $-9.15M | $3.76M | $-14.81M | $-60.87M | $-45.98M | $-33.89M | $-12.31M | $-7.38M | $-35.92M | $-52.99M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $2.83M | $99000.00 | — | $3000.00 | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | $43.22M | $-11.27M | $-17.52M | $-3.78M | — | — | — | — |